Navigation Links
Argos Therapeutics to Present Potential of its Arcelis™ Immunotherapy as an Innovative, Effective Treatment for HIV at the APHA 138th Annual Meeting & Exposition
Date:11/9/2010

DURHAM, N.C., Nov. 9, 2010 /PRNewswire/ -- Argos Therapeutics today announced that Jeff Abbey, the company's president and chief executive officer, will present on the potential of Argos' Arcelis™ immunotherapy as an innovative and effective treatment for HIV at the APHA 138th Annual Meeting & Exposition in Denver, Colo., at 1:45 p.m. MST on Wednesday, Nov. 10. The conference will take place at the Colorado Convention Center.

Data from a Phase 2a trial of Argos' Arcelis HIV program, AGS-004, demonstrated a significant reduction in viral load and a delay in viral rebound kinetics during a 12-week antiretroviral treatment interruption (ARTI) when compared to pre-ART viral loads. AGS-004 is currently being tested in a double-blind, placebo controlled, randomized Phase 2b study co-funded by the NIH to further demonstrate that it is a feasible treatment option of HIV-1 infected patients.

About the Arcelis™ Technology

Arcelis is Argos' proprietary technology for personalizing RNA-loaded dendritic cell immunotherapies for cancer, HIV and other infectious diseases. This platform is based on optimizing a patient's own (autologous) dendritic cells to trigger a tumor- or pathogen-specific immune response. To address the challenge of the unique genetic profile of each patient's disease and the genetic mutations of that disease, Argos loads the autologous dendritic cells with a sample of messenger RNA ("mRNA") isolated from the patient's disease. Through this process, dendritic cells can potentially prime immune responses to the entire antigenic repertoire, resulting in an immunotherapeutic that is customized to the patient's specific disease.

About Argo
'/>"/>

SOURCE Argos Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Argos Therapeutics to Present Overview of its Arcelis™ Dendritic Cell-based Immunotherapy, Participate in Panel Discussion at Inaugural Cancer Immunotherapy Conference
2. Argos Therapeutics to Present Recent Clinical Developments and Corporate Overview at 18th Annual BioPartnering Europe
3. Results From Argos Therapeutics Arcelis™ Immunotherapy Phase 2 Study for Treatment of Renal Cell Carcinoma (RCC) Accepted for Poster Presentation at Ninth International Kidney Cancer Symposium
4. Amicus Therapeutics Announces Third Quarter 2010 Financial Results
5. Mederi Therapeutics Announces Receipt of CE Mark for its Second Generation Secca® and Stretta® Systems
6. Pervasis Therapeutics Awarded Four Grants Under the Qualifying Therapeutic Discovery Project
7. Nektar Therapeutics Reports Third Quarter 2010 Financial Results
8. Orexigen® Therapeutics Reports Third Quarter 2010 Financial Results
9. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
10. Talecris Biotherapeutics Launches PROLASTIN®-C in Canada
11. Cell Therapeutics Awarded $977,917 in Grants Under the Therapeutic Discovery Tax Credit Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Calif. , May 16, 2013 AcelRx Pharmaceuticals, ... focused on the development and commercialization of innovative therapies for ... Richard King , President and CEO, will ... at the Sheraton New York Hotel in New ... May 22, 2013 at 9:30 a.m. ET/6:30 a.m. PT. ...
(Date:5/16/2013)... , May 16, 2013  ULURU Inc. (OTCQB: ULUR) ... March 31, 2013 and provided a review of its operating ... Company is confirming the previously communicated outlook for 2013: ... , Expanding the network of distribution partners to cover all ... , Positioning Altrazeal ® to be marketed in approximately ...
(Date:5/16/2013)... , May 16, 2013  A new survey of ... with vulvar and vaginal atrophy (VVA) are either unaware ... are simply dissatisfied with the therapies available. The REVIVE ... VI ews of Treatment Options for Menopausal Vulvar/ ... the treatment of VVA, including lack of knowledge, reluctance ...
Breaking Medicine Technology:AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 2AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference 3ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 2New Survey Results from 3,000 Postmenopausal Women Living with Vulvar and Vaginal Atrophy 3
... Dec. 16 Cohera Medical Inc. today announced the ... its lead surgical adhesive product, TissuGlu®. Initiation of the ... of the lead product toward clinical practice. , ... to investigate the safety of TissuGlu and its effect ...
... , , HARTFORD, Conn., ... leading provider of home health benefits management services, announced ... from URAC, a Washington, DC-based health care accrediting organization ... URAC standards guarantee that only appropriately trained, qualified clinical ...
Cached Medicine Technology:First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 2First Patient Treated in Clinical Study of Cohera Medical's TissuGlu(R) Surgical Adhesive 3CareCentrix Receives URAC Health Utilization Management Accreditation 2
(Date:5/18/2013)... 18, 2013 Scott Tischler of Tischler Brothers ... These five keys to losing weight played a huge part ... of Scott Tischler, Troy was able to lose a pound ... loss program should be approached with caution and any activity ... the five keys to weight loss that Scott Tischler advocates. ...
(Date:5/18/2013)... May 18, 2013 Wine World Accessories, ... offering its customers an attractive 25% discount on Franmara ... , Customers can now purchase this electric corkscrew opener ... online transactional process. The online store ensures delivery of ... of order placement. , A spokesperson from the ...
(Date:5/18/2013)... the the Stevens Johnson Syndrome Foundation, Stevens Johnson Syndrome (SJS), ... reaction usually to medicine (i). The first signs of ... blistering and large areas of dead skin. Some severe ... any time and seriously affect both children and adults. ... after he received kidney medicine which caused SJS (ii). ...
(Date:5/18/2013)... (PRWEB) May 18, 2013 Three new ... two health and wellness centers and one therapeutic dispensary. ... three locations, the weekend of May 25th – May ... celebrating Memorial Day. All events will take ... May 25th , Elements Therapeutic Dispensary , 10580 S. ...
(Date:5/17/2013)... 2013 Orriant is flexing its ... to businesses across the U.S. with an enhanced ... rigorous infrastructure upgrades for their telecommunications platform, which ... via voice and data. As a company ... healthcare costs and take advantage of federal ...
Breaking Medicine News(10 mins):Health News:Now Save 25% on Franmara Dynamo Electric Wine Bottle Opener at Wine World Accessories 2Health News:Injury Law Firm Announces New Informative Graphic on Common Medicines That Have Allegedly Been Linked to Stevens Johnson Syndrome 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 2Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 3Health News:Elements Honors Medical Marijuana Patients at Elements Health and Wellness Centers and Elements Therapeutic Dispensary 4Health News:New Telecommunications Upgrade Provides More Capacity for National Corporate Wellness Programs offered by Orriant 2
... may have a way to make the powerful cancer drug ... some cancers. The chemotherapeutic agent used in combination with other ... or failure in about 30 percent of users, although the ... to protect the kidneys is advise patients to drink more ...
... News) -- A man,s heart disease risk after the age of ... body size and placenta size when he was born, a new ... lifetime nutrition and the early growth of her child," study lead ... University of Southampton in the United Kingdom, said in a news ...
... study published in the journal Clinical Cardiology ... resynchronization therapy (CRT) improves patients, libido, erectile dysfunction, and ... complex clinical syndrome characterized by fatigue and exercise intolerance. ... CRT, which is a type of pacemaker that paces ...
... Physicians can help their patients follow prescribed ... chronic disease management by using a three-pronged ... the University of California, Riverside, Texas State University-San ... The Information-Motivation-Strategy (IMS) Model developed after ...
... at the University of Southern California have pinned down ... survival trait: our ability to comprehend a sceneeven one ... The key is to process the interacting objects ... according to corresponding author Irving Biederman, professor of psychology ...
... hurdles in obtaining an appointment for care with an ... of Medicine at the University of Pennnsylvania that will ... meeting of American Society of Clinical Oncology (Abstract #6128). ... an appointment, with just 22 percent of them obtaining ...
Cached Medicine News:Health News:Cause and potential treatment found for cancer drug's kidney toxicity 2Health News:Male Heart Disease May Be Linked to Mom's Lifetime Nutrition 2Health News:Researchers develop strategy to improve patient adherence 2Health News:Researchers develop strategy to improve patient adherence 3Health News:USC study locates the source of key brain function 2Health News:Two-thirds of newly diagnosed cancer patients unable to obtain oncology appointments 2
... Includes PowerPac 200 power ... Range of Parameters. Quantitative Transfers. ... or Overnight Transfers. Faster, ... High Field-Intensity Transfers with ...
The Trans-Blot transfer cell, used with the included PowerPac 200 power supply, performs efficient, high-intensity electrophoretic transfers. The Trans-Blot cell offers many advantages....
... running Criterion precast gels and Criterion ... fit for use with the incredible ... Criterion blotter combines excellent blotting efficiency ... system and the ease-of-use of the ...
... SD semi-dry transfer cell allows ... Using a platinum-coated titanium plate ... stainless steel plate as the ... transfers in a horizontal configuration ...
Medicine Products: